Skip to main content

Novo Nordisk, maker of Ozempic and Wegovy, to invest more than $6 billion to expand production

Drugmaker set to expand Danish facilities amid ongoing Wegovy shortage.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.